Global Drug based on CAR T-Cell Market Research Report 2024, Forecast to 2032
Report Overview
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global Drug based on CAR T-Cell market size was estimated at USD 366 million in 2023 and is projected to reach USD 672.88 million by 2032, exhibiting a CAGR of 7.00% during the forecast period.
North America Drug based on CAR T-Cell market size was estimated at USD 107.16 million in 2023, at a CAGR of 6.00% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug based on CAR T-Cell Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug based on CAR T-Cell market in any manner.
Global Drug based on CAR T-Cell Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug based on CAR T-Cell Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug based on CAR T-Cell, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global Drug based on CAR T-Cell market size was estimated at USD 366 million in 2023 and is projected to reach USD 672.88 million by 2032, exhibiting a CAGR of 7.00% during the forecast period.
North America Drug based on CAR T-Cell market size was estimated at USD 107.16 million in 2023, at a CAGR of 6.00% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug based on CAR T-Cell Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug based on CAR T-Cell market in any manner.
Global Drug based on CAR T-Cell Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug based on CAR T-Cell Market
- Overview of the regional outlook of the Drug based on CAR T-Cell Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug based on CAR T-Cell Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug based on CAR T-Cell, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug based on CAR T-Cell
1.2 Key Market Segments
1.2.1 Drug based on CAR T-Cell Segment by Type
1.2.2 Drug based on CAR T-Cell Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG BASED ON CAR T-CELL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug based on CAR T-Cell Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Drug based on CAR T-Cell Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG BASED ON CAR T-CELL MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug based on CAR T-Cell Sales by Manufacturers (2019-2024)
3.2 Global Drug based on CAR T-Cell Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug based on CAR T-Cell Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug based on CAR T-Cell Sales Sites, Area Served, Product Type
3.6 Drug based on CAR T-Cell Market Competitive Situation and Trends
3.6.1 Drug based on CAR T-Cell Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug based on CAR T-Cell Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG BASED ON CAR T-CELL INDUSTRY CHAIN ANALYSIS
4.1 Drug based on CAR T-Cell Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG BASED ON CAR T-CELL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG BASED ON CAR T-CELL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug based on CAR T-Cell Sales Market Share by Type (2019-2024)
6.3 Global Drug based on CAR T-Cell Market Size Market Share by Type (2019-2024)
6.4 Global Drug based on CAR T-Cell Price by Type (2019-2024)
7 DRUG BASED ON CAR T-CELL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug based on CAR T-Cell Market Sales by Application (2019-2024)
7.3 Global Drug based on CAR T-Cell Market Size (M USD) by Application (2019-2024)
7.4 Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
8 DRUG BASED ON CAR T-CELL MARKET CONSUMPTION BY REGION
8.1 Global Drug based on CAR T-Cell Sales by Region
8.1.1 Global Drug based on CAR T-Cell Sales by Region
8.1.2 Global Drug based on CAR T-Cell Sales Market Share by Region
8.2 North America
8.2.1 North America Drug based on CAR T-Cell Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug based on CAR T-Cell Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug based on CAR T-Cell Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug based on CAR T-Cell Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug based on CAR T-Cell Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 DRUG BASED ON CAR T-CELL MARKET PRODUCTION BY REGION
9.1 Global Production of Drug based on CAR T-Cell by Region (2019-2024)
9.2 Global Drug based on CAR T-Cell Revenue Market Share by Region (2019-2024)
9.3 Global Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Drug based on CAR T-Cell Production
9.4.1 North America Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.4.2 North America Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Drug based on CAR T-Cell Production
9.5.1 Europe Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.5.2 Europe Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Drug based on CAR T-Cell Production (2019-2024)
9.6.1 Japan Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.6.2 Japan Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Drug based on CAR T-Cell Production (2019-2024)
9.7.1 China Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.7.2 China Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Drug based on CAR T-Cell Basic Information
10.1.2 Novartis Drug based on CAR T-Cell Product Overview
10.1.3 Novartis Drug based on CAR T-Cell Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Drug based on CAR T-Cell SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Drug based on CAR T-Cell Basic Information
10.2.2 Gilead Sciences Drug based on CAR T-Cell Product Overview
10.2.3 Gilead Sciences Drug based on CAR T-Cell Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences Drug based on CAR T-Cell SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Drug based on CAR T-Cell Basic Information
10.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Overview
10.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Product Market Performance
10.3.4 Bristol-Myers Squibb Drug based on CAR T-Cell SWOT Analysis
10.3.5 Bristol-Myers Squibb Business Overview
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Drug based on CAR T-Cell Basic Information
10.4.2 J and J Drug based on CAR T-Cell Product Overview
10.4.3 J and J Drug based on CAR T-Cell Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Drug based on CAR T-Cell Basic Information
10.5.2 JW Therapeutics Drug based on CAR T-Cell Product Overview
10.5.3 JW Therapeutics Drug based on CAR T-Cell Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Drug based on CAR T-Cell Basic Information
10.6.2 FOSUNKite Drug based on CAR T-Cell Product Overview
10.6.3 FOSUNKite Drug based on CAR T-Cell Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Drug based on CAR T-Cell Basic Information
10.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Overview
10.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Product Market Performance
10.8.4 CARsgen Therapeutics Business Overview
10.8.5 CARsgen Therapeutics Recent Developments
10.9 Autolus Therapeutics
10.9.1 Autolus Therapeutics Drug based on CAR T-Cell Basic Information
10.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Overview
10.9.3 Autolus Therapeutics Drug based on CAR T-Cell Product Market Performance
10.9.4 Autolus Therapeutics Business Overview
10.9.5 Autolus Therapeutics Recent Developments
10.10 Sorrento Therapeutics
10.10.1 Sorrento Therapeutics Drug based on CAR T-Cell Basic Information
10.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Overview
10.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Product Market Performance
10.10.4 Sorrento Therapeutics Business Overview
10.10.5 Sorrento Therapeutics Recent Developments
10.11 Mustang Bio
10.11.1 Mustang Bio Drug based on CAR T-Cell Basic Information
10.11.2 Mustang Bio Drug based on CAR T-Cell Product Overview
10.11.3 Mustang Bio Drug based on CAR T-Cell Product Market Performance
10.11.4 Mustang Bio Business Overview
10.11.5 Mustang Bio Recent Developments
10.12 Bluebird Bio
10.12.1 Bluebird Bio Drug based on CAR T-Cell Basic Information
10.12.2 Bluebird Bio Drug based on CAR T-Cell Product Overview
10.12.3 Bluebird Bio Drug based on CAR T-Cell Product Market Performance
10.12.4 Bluebird Bio Business Overview
10.12.5 Bluebird Bio Recent Developments
10.13 Cellectis
10.13.1 Cellectis Drug based on CAR T-Cell Basic Information
10.13.2 Cellectis Drug based on CAR T-Cell Product Overview
10.13.3 Cellectis Drug based on CAR T-Cell Product Market Performance
10.13.4 Cellectis Business Overview
10.13.5 Cellectis Recent Developments
10.14 Allogene Therapeutics
10.14.1 Allogene Therapeutics Drug based on CAR T-Cell Basic Information
10.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Overview
10.14.3 Allogene Therapeutics Drug based on CAR T-Cell Product Market Performance
10.14.4 Allogene Therapeutics Business Overview
10.14.5 Allogene Therapeutics Recent Developments
10.15 Celyad
10.15.1 Celyad Drug based on CAR T-Cell Basic Information
10.15.2 Celyad Drug based on CAR T-Cell Product Overview
10.15.3 Celyad Drug based on CAR T-Cell Product Market Performance
10.15.4 Celyad Business Overview
10.15.5 Celyad Recent Developments
11 DRUG BASED ON CAR T-CELL MARKET FORECAST BY REGION
11.1 Global Drug based on CAR T-Cell Market Size Forecast
11.2 Global Drug based on CAR T-Cell Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug based on CAR T-Cell Market Size Forecast by Country
11.2.3 Asia Pacific Drug based on CAR T-Cell Market Size Forecast by Region
11.2.4 South America Drug based on CAR T-Cell Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Drug based on CAR T-Cell by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Drug based on CAR T-Cell Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Drug based on CAR T-Cell by Type (2025-2032)
12.1.2 Global Drug based on CAR T-Cell Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Drug based on CAR T-Cell by Type (2025-2032)
12.2 Global Drug based on CAR T-Cell Market Forecast by Application (2025-2032)
12.2.1 Global Drug based on CAR T-Cell Sales (K MT) Forecast by Application
12.2.2 Global Drug based on CAR T-Cell Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug based on CAR T-Cell
1.2 Key Market Segments
1.2.1 Drug based on CAR T-Cell Segment by Type
1.2.2 Drug based on CAR T-Cell Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG BASED ON CAR T-CELL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug based on CAR T-Cell Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Drug based on CAR T-Cell Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG BASED ON CAR T-CELL MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug based on CAR T-Cell Sales by Manufacturers (2019-2024)
3.2 Global Drug based on CAR T-Cell Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug based on CAR T-Cell Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug based on CAR T-Cell Sales Sites, Area Served, Product Type
3.6 Drug based on CAR T-Cell Market Competitive Situation and Trends
3.6.1 Drug based on CAR T-Cell Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug based on CAR T-Cell Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG BASED ON CAR T-CELL INDUSTRY CHAIN ANALYSIS
4.1 Drug based on CAR T-Cell Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG BASED ON CAR T-CELL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG BASED ON CAR T-CELL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug based on CAR T-Cell Sales Market Share by Type (2019-2024)
6.3 Global Drug based on CAR T-Cell Market Size Market Share by Type (2019-2024)
6.4 Global Drug based on CAR T-Cell Price by Type (2019-2024)
7 DRUG BASED ON CAR T-CELL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug based on CAR T-Cell Market Sales by Application (2019-2024)
7.3 Global Drug based on CAR T-Cell Market Size (M USD) by Application (2019-2024)
7.4 Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
8 DRUG BASED ON CAR T-CELL MARKET CONSUMPTION BY REGION
8.1 Global Drug based on CAR T-Cell Sales by Region
8.1.1 Global Drug based on CAR T-Cell Sales by Region
8.1.2 Global Drug based on CAR T-Cell Sales Market Share by Region
8.2 North America
8.2.1 North America Drug based on CAR T-Cell Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug based on CAR T-Cell Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug based on CAR T-Cell Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug based on CAR T-Cell Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug based on CAR T-Cell Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 DRUG BASED ON CAR T-CELL MARKET PRODUCTION BY REGION
9.1 Global Production of Drug based on CAR T-Cell by Region (2019-2024)
9.2 Global Drug based on CAR T-Cell Revenue Market Share by Region (2019-2024)
9.3 Global Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Drug based on CAR T-Cell Production
9.4.1 North America Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.4.2 North America Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Drug based on CAR T-Cell Production
9.5.1 Europe Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.5.2 Europe Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Drug based on CAR T-Cell Production (2019-2024)
9.6.1 Japan Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.6.2 Japan Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Drug based on CAR T-Cell Production (2019-2024)
9.7.1 China Drug based on CAR T-Cell Production Growth Rate (2019-2024)
9.7.2 China Drug based on CAR T-Cell Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Drug based on CAR T-Cell Basic Information
10.1.2 Novartis Drug based on CAR T-Cell Product Overview
10.1.3 Novartis Drug based on CAR T-Cell Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Drug based on CAR T-Cell SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Drug based on CAR T-Cell Basic Information
10.2.2 Gilead Sciences Drug based on CAR T-Cell Product Overview
10.2.3 Gilead Sciences Drug based on CAR T-Cell Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences Drug based on CAR T-Cell SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Drug based on CAR T-Cell Basic Information
10.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Overview
10.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Product Market Performance
10.3.4 Bristol-Myers Squibb Drug based on CAR T-Cell SWOT Analysis
10.3.5 Bristol-Myers Squibb Business Overview
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Drug based on CAR T-Cell Basic Information
10.4.2 J and J Drug based on CAR T-Cell Product Overview
10.4.3 J and J Drug based on CAR T-Cell Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Drug based on CAR T-Cell Basic Information
10.5.2 JW Therapeutics Drug based on CAR T-Cell Product Overview
10.5.3 JW Therapeutics Drug based on CAR T-Cell Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Drug based on CAR T-Cell Basic Information
10.6.2 FOSUNKite Drug based on CAR T-Cell Product Overview
10.6.3 FOSUNKite Drug based on CAR T-Cell Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Drug based on CAR T-Cell Basic Information
10.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Overview
10.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Product Market Performance
10.8.4 CARsgen Therapeutics Business Overview
10.8.5 CARsgen Therapeutics Recent Developments
10.9 Autolus Therapeutics
10.9.1 Autolus Therapeutics Drug based on CAR T-Cell Basic Information
10.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Overview
10.9.3 Autolus Therapeutics Drug based on CAR T-Cell Product Market Performance
10.9.4 Autolus Therapeutics Business Overview
10.9.5 Autolus Therapeutics Recent Developments
10.10 Sorrento Therapeutics
10.10.1 Sorrento Therapeutics Drug based on CAR T-Cell Basic Information
10.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Overview
10.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Product Market Performance
10.10.4 Sorrento Therapeutics Business Overview
10.10.5 Sorrento Therapeutics Recent Developments
10.11 Mustang Bio
10.11.1 Mustang Bio Drug based on CAR T-Cell Basic Information
10.11.2 Mustang Bio Drug based on CAR T-Cell Product Overview
10.11.3 Mustang Bio Drug based on CAR T-Cell Product Market Performance
10.11.4 Mustang Bio Business Overview
10.11.5 Mustang Bio Recent Developments
10.12 Bluebird Bio
10.12.1 Bluebird Bio Drug based on CAR T-Cell Basic Information
10.12.2 Bluebird Bio Drug based on CAR T-Cell Product Overview
10.12.3 Bluebird Bio Drug based on CAR T-Cell Product Market Performance
10.12.4 Bluebird Bio Business Overview
10.12.5 Bluebird Bio Recent Developments
10.13 Cellectis
10.13.1 Cellectis Drug based on CAR T-Cell Basic Information
10.13.2 Cellectis Drug based on CAR T-Cell Product Overview
10.13.3 Cellectis Drug based on CAR T-Cell Product Market Performance
10.13.4 Cellectis Business Overview
10.13.5 Cellectis Recent Developments
10.14 Allogene Therapeutics
10.14.1 Allogene Therapeutics Drug based on CAR T-Cell Basic Information
10.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Overview
10.14.3 Allogene Therapeutics Drug based on CAR T-Cell Product Market Performance
10.14.4 Allogene Therapeutics Business Overview
10.14.5 Allogene Therapeutics Recent Developments
10.15 Celyad
10.15.1 Celyad Drug based on CAR T-Cell Basic Information
10.15.2 Celyad Drug based on CAR T-Cell Product Overview
10.15.3 Celyad Drug based on CAR T-Cell Product Market Performance
10.15.4 Celyad Business Overview
10.15.5 Celyad Recent Developments
11 DRUG BASED ON CAR T-CELL MARKET FORECAST BY REGION
11.1 Global Drug based on CAR T-Cell Market Size Forecast
11.2 Global Drug based on CAR T-Cell Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug based on CAR T-Cell Market Size Forecast by Country
11.2.3 Asia Pacific Drug based on CAR T-Cell Market Size Forecast by Region
11.2.4 South America Drug based on CAR T-Cell Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Drug based on CAR T-Cell by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Drug based on CAR T-Cell Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Drug based on CAR T-Cell by Type (2025-2032)
12.1.2 Global Drug based on CAR T-Cell Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Drug based on CAR T-Cell by Type (2025-2032)
12.2 Global Drug based on CAR T-Cell Market Forecast by Application (2025-2032)
12.2.1 Global Drug based on CAR T-Cell Sales (K MT) Forecast by Application
12.2.2 Global Drug based on CAR T-Cell Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug based on CAR T-Cell Market Size Comparison by Region (M USD)
Table 5. Global Drug based on CAR T-Cell Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Drug based on CAR T-Cell Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug based on CAR T-Cell Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug based on CAR T-Cell Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Table 10. Global Market Drug based on CAR T-Cell Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug based on CAR T-Cell Sales Sites and Area Served
Table 12. Manufacturers Drug based on CAR T-Cell Product Type
Table 13. Global Drug based on CAR T-Cell Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug based on CAR T-Cell
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug based on CAR T-Cell Market Challenges
Table 22. Global Drug based on CAR T-Cell Sales by Type (K MT)
Table 23. Global Drug based on CAR T-Cell Market Size by Type (M USD)
Table 24. Global Drug based on CAR T-Cell Sales (K MT) by Type (2019-2024)
Table 25. Global Drug based on CAR T-Cell Sales Market Share by Type (2019-2024)
Table 26. Global Drug based on CAR T-Cell Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug based on CAR T-Cell Market Size Share by Type (2019-2024)
Table 28. Global Drug based on CAR T-Cell Price (USD/MT) by Type (2019-2024)
Table 29. Global Drug based on CAR T-Cell Sales (K MT) by Application
Table 30. Global Drug based on CAR T-Cell Market Size by Application
Table 31. Global Drug based on CAR T-Cell Sales by Application (2019-2024) & (K MT)
Table 32. Global Drug based on CAR T-Cell Sales Market Share by Application (2019-2024)
Table 33. Global Drug based on CAR T-Cell Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug based on CAR T-Cell Market Share by Application (2019-2024)
Table 35. Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 37. Global Drug based on CAR T-Cell Sales Market Share by Region (2019-2024)
Table 38. North America Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 39. Europe Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 41. South America Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 43. Global Drug based on CAR T-Cell Production (K MT) by Region (2019-2024)
Table 44. Global Drug based on CAR T-Cell Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Drug based on CAR T-Cell Revenue Market Share by Region (2019-2024)
Table 46. Global Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novartis Drug based on CAR T-Cell Basic Information
Table 52. Novartis Drug based on CAR T-Cell Product Overview
Table 53. Novartis Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novartis Business Overview
Table 55. Novartis Drug based on CAR T-Cell SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Gilead Sciences Drug based on CAR T-Cell Basic Information
Table 58. Gilead Sciences Drug based on CAR T-Cell Product Overview
Table 59. Gilead Sciences Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences Drug based on CAR T-Cell SWOT Analysis
Table 62. Gilead Sciences Recent Developments
Table 63. Bristol-Myers Squibb Drug based on CAR T-Cell Basic Information
Table 64. Bristol-Myers Squibb Drug based on CAR T-Cell Product Overview
Table 65. Bristol-Myers Squibb Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Bristol-Myers Squibb Drug based on CAR T-Cell SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. J and J Drug based on CAR T-Cell Basic Information
Table 70. J and J Drug based on CAR T-Cell Product Overview
Table 71. J and J Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. J and J Business Overview
Table 73. J and J Recent Developments
Table 74. JW Therapeutics Drug based on CAR T-Cell Basic Information
Table 75. JW Therapeutics Drug based on CAR T-Cell Product Overview
Table 76. JW Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics Recent Developments
Table 79. FOSUNKite Drug based on CAR T-Cell Basic Information
Table 80. FOSUNKite Drug based on CAR T-Cell Product Overview
Table 81. FOSUNKite Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. FOSUNKite Business Overview
Table 83. FOSUNKite Recent Developments
Table 84. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Basic Information
Table 85. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Overview
Table 86. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. CARsgen Therapeutics (Pipeline) Business Overview
Table 88. CARsgen Therapeutics (Pipeline) Recent Developments
Table 89. CARsgen Therapeutics Drug based on CAR T-Cell Basic Information
Table 90. CARsgen Therapeutics Drug based on CAR T-Cell Product Overview
Table 91. CARsgen Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. CARsgen Therapeutics Business Overview
Table 93. CARsgen Therapeutics Recent Developments
Table 94. Autolus Therapeutics Drug based on CAR T-Cell Basic Information
Table 95. Autolus Therapeutics Drug based on CAR T-Cell Product Overview
Table 96. Autolus Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Autolus Therapeutics Business Overview
Table 98. Autolus Therapeutics Recent Developments
Table 99. Sorrento Therapeutics Drug based on CAR T-Cell Basic Information
Table 100. Sorrento Therapeutics Drug based on CAR T-Cell Product Overview
Table 101. Sorrento Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sorrento Therapeutics Business Overview
Table 103. Sorrento Therapeutics Recent Developments
Table 104. Mustang Bio Drug based on CAR T-Cell Basic Information
Table 105. Mustang Bio Drug based on CAR T-Cell Product Overview
Table 106. Mustang Bio Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Mustang Bio Business Overview
Table 108. Mustang Bio Recent Developments
Table 109. Bluebird Bio Drug based on CAR T-Cell Basic Information
Table 110. Bluebird Bio Drug based on CAR T-Cell Product Overview
Table 111. Bluebird Bio Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bluebird Bio Business Overview
Table 113. Bluebird Bio Recent Developments
Table 114. Cellectis Drug based on CAR T-Cell Basic Information
Table 115. Cellectis Drug based on CAR T-Cell Product Overview
Table 116. Cellectis Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Cellectis Business Overview
Table 118. Cellectis Recent Developments
Table 119. Allogene Therapeutics Drug based on CAR T-Cell Basic Information
Table 120. Allogene Therapeutics Drug based on CAR T-Cell Product Overview
Table 121. Allogene Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Allogene Therapeutics Business Overview
Table 123. Allogene Therapeutics Recent Developments
Table 124. Celyad Drug based on CAR T-Cell Basic Information
Table 125. Celyad Drug based on CAR T-Cell Product Overview
Table 126. Celyad Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Celyad Business Overview
Table 128. Celyad Recent Developments
Table 129. Global Drug based on CAR T-Cell Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Drug based on CAR T-Cell Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Drug based on CAR T-Cell Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Drug based on CAR T-Cell Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Drug based on CAR T-Cell Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Drug based on CAR T-Cell Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Drug based on CAR T-Cell Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Drug based on CAR T-Cell Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Drug based on CAR T-Cell Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Drug based on CAR T-Cell Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug based on CAR T-Cell Market Size Comparison by Region (M USD)
Table 5. Global Drug based on CAR T-Cell Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Drug based on CAR T-Cell Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug based on CAR T-Cell Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug based on CAR T-Cell Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Table 10. Global Market Drug based on CAR T-Cell Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug based on CAR T-Cell Sales Sites and Area Served
Table 12. Manufacturers Drug based on CAR T-Cell Product Type
Table 13. Global Drug based on CAR T-Cell Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug based on CAR T-Cell
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug based on CAR T-Cell Market Challenges
Table 22. Global Drug based on CAR T-Cell Sales by Type (K MT)
Table 23. Global Drug based on CAR T-Cell Market Size by Type (M USD)
Table 24. Global Drug based on CAR T-Cell Sales (K MT) by Type (2019-2024)
Table 25. Global Drug based on CAR T-Cell Sales Market Share by Type (2019-2024)
Table 26. Global Drug based on CAR T-Cell Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug based on CAR T-Cell Market Size Share by Type (2019-2024)
Table 28. Global Drug based on CAR T-Cell Price (USD/MT) by Type (2019-2024)
Table 29. Global Drug based on CAR T-Cell Sales (K MT) by Application
Table 30. Global Drug based on CAR T-Cell Market Size by Application
Table 31. Global Drug based on CAR T-Cell Sales by Application (2019-2024) & (K MT)
Table 32. Global Drug based on CAR T-Cell Sales Market Share by Application (2019-2024)
Table 33. Global Drug based on CAR T-Cell Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug based on CAR T-Cell Market Share by Application (2019-2024)
Table 35. Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 37. Global Drug based on CAR T-Cell Sales Market Share by Region (2019-2024)
Table 38. North America Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 39. Europe Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 41. South America Drug based on CAR T-Cell Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Drug based on CAR T-Cell Sales by Region (2019-2024) & (K MT)
Table 43. Global Drug based on CAR T-Cell Production (K MT) by Region (2019-2024)
Table 44. Global Drug based on CAR T-Cell Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Drug based on CAR T-Cell Revenue Market Share by Region (2019-2024)
Table 46. Global Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Drug based on CAR T-Cell Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novartis Drug based on CAR T-Cell Basic Information
Table 52. Novartis Drug based on CAR T-Cell Product Overview
Table 53. Novartis Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novartis Business Overview
Table 55. Novartis Drug based on CAR T-Cell SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Gilead Sciences Drug based on CAR T-Cell Basic Information
Table 58. Gilead Sciences Drug based on CAR T-Cell Product Overview
Table 59. Gilead Sciences Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences Drug based on CAR T-Cell SWOT Analysis
Table 62. Gilead Sciences Recent Developments
Table 63. Bristol-Myers Squibb Drug based on CAR T-Cell Basic Information
Table 64. Bristol-Myers Squibb Drug based on CAR T-Cell Product Overview
Table 65. Bristol-Myers Squibb Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Bristol-Myers Squibb Drug based on CAR T-Cell SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. J and J Drug based on CAR T-Cell Basic Information
Table 70. J and J Drug based on CAR T-Cell Product Overview
Table 71. J and J Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. J and J Business Overview
Table 73. J and J Recent Developments
Table 74. JW Therapeutics Drug based on CAR T-Cell Basic Information
Table 75. JW Therapeutics Drug based on CAR T-Cell Product Overview
Table 76. JW Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics Recent Developments
Table 79. FOSUNKite Drug based on CAR T-Cell Basic Information
Table 80. FOSUNKite Drug based on CAR T-Cell Product Overview
Table 81. FOSUNKite Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. FOSUNKite Business Overview
Table 83. FOSUNKite Recent Developments
Table 84. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Basic Information
Table 85. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Overview
Table 86. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. CARsgen Therapeutics (Pipeline) Business Overview
Table 88. CARsgen Therapeutics (Pipeline) Recent Developments
Table 89. CARsgen Therapeutics Drug based on CAR T-Cell Basic Information
Table 90. CARsgen Therapeutics Drug based on CAR T-Cell Product Overview
Table 91. CARsgen Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. CARsgen Therapeutics Business Overview
Table 93. CARsgen Therapeutics Recent Developments
Table 94. Autolus Therapeutics Drug based on CAR T-Cell Basic Information
Table 95. Autolus Therapeutics Drug based on CAR T-Cell Product Overview
Table 96. Autolus Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Autolus Therapeutics Business Overview
Table 98. Autolus Therapeutics Recent Developments
Table 99. Sorrento Therapeutics Drug based on CAR T-Cell Basic Information
Table 100. Sorrento Therapeutics Drug based on CAR T-Cell Product Overview
Table 101. Sorrento Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sorrento Therapeutics Business Overview
Table 103. Sorrento Therapeutics Recent Developments
Table 104. Mustang Bio Drug based on CAR T-Cell Basic Information
Table 105. Mustang Bio Drug based on CAR T-Cell Product Overview
Table 106. Mustang Bio Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Mustang Bio Business Overview
Table 108. Mustang Bio Recent Developments
Table 109. Bluebird Bio Drug based on CAR T-Cell Basic Information
Table 110. Bluebird Bio Drug based on CAR T-Cell Product Overview
Table 111. Bluebird Bio Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bluebird Bio Business Overview
Table 113. Bluebird Bio Recent Developments
Table 114. Cellectis Drug based on CAR T-Cell Basic Information
Table 115. Cellectis Drug based on CAR T-Cell Product Overview
Table 116. Cellectis Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Cellectis Business Overview
Table 118. Cellectis Recent Developments
Table 119. Allogene Therapeutics Drug based on CAR T-Cell Basic Information
Table 120. Allogene Therapeutics Drug based on CAR T-Cell Product Overview
Table 121. Allogene Therapeutics Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Allogene Therapeutics Business Overview
Table 123. Allogene Therapeutics Recent Developments
Table 124. Celyad Drug based on CAR T-Cell Basic Information
Table 125. Celyad Drug based on CAR T-Cell Product Overview
Table 126. Celyad Drug based on CAR T-Cell Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Celyad Business Overview
Table 128. Celyad Recent Developments
Table 129. Global Drug based on CAR T-Cell Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Drug based on CAR T-Cell Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Drug based on CAR T-Cell Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Drug based on CAR T-Cell Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Drug based on CAR T-Cell Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Drug based on CAR T-Cell Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Drug based on CAR T-Cell Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Drug based on CAR T-Cell Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Drug based on CAR T-Cell Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Drug based on CAR T-Cell Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Drug based on CAR T-Cell Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Drug based on CAR T-Cell Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug based on CAR T-Cell
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug based on CAR T-Cell Market Size (M USD), 2019-2032
Figure 5. Global Drug based on CAR T-Cell Market Size (M USD) (2019-2032)
Figure 6. Global Drug based on CAR T-Cell Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug based on CAR T-Cell Market Size by Country (M USD)
Figure 11. Drug based on CAR T-Cell Sales Share by Manufacturers in 2023
Figure 12. Global Drug based on CAR T-Cell Revenue Share by Manufacturers in 2023
Figure 13. Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug based on CAR T-Cell Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug based on CAR T-Cell Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug based on CAR T-Cell Market Share by Type
Figure 18. Sales Market Share of Drug based on CAR T-Cell by Type (2019-2024)
Figure 19. Sales Market Share of Drug based on CAR T-Cell by Type in 2023
Figure 20. Market Size Share of Drug based on CAR T-Cell by Type (2019-2024)
Figure 21. Market Size Market Share of Drug based on CAR T-Cell by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug based on CAR T-Cell Market Share by Application
Figure 24. Global Drug based on CAR T-Cell Sales Market Share by Application (2019-2024)
Figure 25. Global Drug based on CAR T-Cell Sales Market Share by Application in 2023
Figure 26. Global Drug based on CAR T-Cell Market Share by Application (2019-2024)
Figure 27. Global Drug based on CAR T-Cell Market Share by Application in 2023
Figure 28. Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug based on CAR T-Cell Sales Market Share by Region (2019-2024)
Figure 30. North America Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 32. U.S. Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Drug based on CAR T-Cell Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Drug based on CAR T-Cell Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 37. Germany Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Drug based on CAR T-Cell Sales Market Share by Region in 2023
Figure 44. China Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 50. South America Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 51. Brazil Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Drug based on CAR T-Cell Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Drug based on CAR T-Cell Production Market Share by Region (2019-2024)
Figure 62. North America Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 65. China Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Drug based on CAR T-Cell Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Drug based on CAR T-Cell Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Drug based on CAR T-Cell Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Drug based on CAR T-Cell Market Share Forecast by Type (2025-2032)
Figure 70. Global Drug based on CAR T-Cell Sales Forecast by Application (2025-2032)
Figure 71. Global Drug based on CAR T-Cell Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Drug based on CAR T-Cell
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug based on CAR T-Cell Market Size (M USD), 2019-2032
Figure 5. Global Drug based on CAR T-Cell Market Size (M USD) (2019-2032)
Figure 6. Global Drug based on CAR T-Cell Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug based on CAR T-Cell Market Size by Country (M USD)
Figure 11. Drug based on CAR T-Cell Sales Share by Manufacturers in 2023
Figure 12. Global Drug based on CAR T-Cell Revenue Share by Manufacturers in 2023
Figure 13. Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug based on CAR T-Cell Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug based on CAR T-Cell Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug based on CAR T-Cell Market Share by Type
Figure 18. Sales Market Share of Drug based on CAR T-Cell by Type (2019-2024)
Figure 19. Sales Market Share of Drug based on CAR T-Cell by Type in 2023
Figure 20. Market Size Share of Drug based on CAR T-Cell by Type (2019-2024)
Figure 21. Market Size Market Share of Drug based on CAR T-Cell by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug based on CAR T-Cell Market Share by Application
Figure 24. Global Drug based on CAR T-Cell Sales Market Share by Application (2019-2024)
Figure 25. Global Drug based on CAR T-Cell Sales Market Share by Application in 2023
Figure 26. Global Drug based on CAR T-Cell Market Share by Application (2019-2024)
Figure 27. Global Drug based on CAR T-Cell Market Share by Application in 2023
Figure 28. Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug based on CAR T-Cell Sales Market Share by Region (2019-2024)
Figure 30. North America Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 32. U.S. Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Drug based on CAR T-Cell Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Drug based on CAR T-Cell Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 37. Germany Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Drug based on CAR T-Cell Sales Market Share by Region in 2023
Figure 44. China Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 50. South America Drug based on CAR T-Cell Sales Market Share by Country in 2023
Figure 51. Brazil Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Drug based on CAR T-Cell Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Drug based on CAR T-Cell Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Drug based on CAR T-Cell Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Drug based on CAR T-Cell Production Market Share by Region (2019-2024)
Figure 62. North America Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 65. China Drug based on CAR T-Cell Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Drug based on CAR T-Cell Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Drug based on CAR T-Cell Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Drug based on CAR T-Cell Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Drug based on CAR T-Cell Market Share Forecast by Type (2025-2032)
Figure 70. Global Drug based on CAR T-Cell Sales Forecast by Application (2025-2032)
Figure 71. Global Drug based on CAR T-Cell Market Share Forecast by Application (2025-2032)
